Below is information about GENELUX COMPANY HEADQUARTERS from a variety of sources. Please take a look at the materials that our team has selected for you.
https://www.genelux.com/about/
Our headquarters and business office facilities are located in the Los Angeles region, an emerging biotech hub. Our R&D and manufacturing facilities are located in San Diego, one of the premier biotech hubs In the United States.
GENELUX. Clinical-stage biopharmaceutical company evaluating a flexible and powerful therapeutic modality with the potential to redefine immuno-oncology. LEARN MORE. REDEFINE. Redefining immuno-oncology by developing compounds that have the potential to overcome some of the most significant challenges associated with solid tumors. LEARN MORE.
https://www.genelux.com/contact/
Genelux does not recruit or select patients for clinical trials. Information about selection can be obtained from participating clinical partners or at www.clinicaltrials.gov . GENERAL INFORMATION . For general information, please contact: Telephone: (858) 483-0024 Email: [email protected]
https://en.wikipedia.org/wiki/Genelux_Corporation
https://www.dnb.com/business-directory/company-profiles.genelux_corporation.c1ece7f95b35014963f423ee90e89982.html
Company Description: Genelux Corporation is located in Redlands, CA, United States and is part of the Drugs and Druggists' Sundries Merchant Wholesalers Industry. Genelux Corporation has 1 employees at this location. (Employees figure is modelled). There are 2 companies in the Genelux Corporation corporate family.
Genelux is a clinical-stage biopharmaceutical company developing a proprietary oncolytic virus-based technology platform and a pipeline of products with applications for cancer detection and therapy. Its lead oncology product candidate, GL-ONC1, is an attenuated vaccina virus that results in regression and elimination of a range of solid tumors ...
https://www.genelux.com/investors/
The Genelux Difference. Genelux is a clinical-stage biopharmaceutical company evaluating flexible and powerful therapeutics that could potentially redefine immuno-oncology. The Company is developing a pipeline of next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.
https://www.genelux.com/overview/
A robust clinical pipeline advancing two programs with significant potential: an Ovarian Cancer program (regional delivery into the abdominal cavity) and a Systemic delivery program (IV delivery) Regional (IPE) route maximizes pharmacokinetics (PK) & tumor tissue exposure. Systemic (IV) routes maximize the addressable indications.
https://pitchbook.com/profiles/company/65548-99
Genelux General Information Description. Operator of a bio-pharmaceutical agency intended to develop oncology drugs. The company's agency develops a proprietary oncolytic virus-based technology platform and deep pipeline of products that have broad applications for cancer detection and therapy, enabling patients and health care institutions to access products that …
https://www.bloomberg.com/profile/company/0713626D:US
Genelux Corp was founded in 2002. The company's line of business includes providing commercial physical and biological research and development. SECTOR. Health Care. INDUSTRY. Health Care. SUB ...
Did you find the information you need about GENELUX COMPANY HEADQUARTERS?
We hope you found all the information about GENELUX COMPANY HEADQUARTERS you were looking for and more.
